Summary
Johnson & Johnson (JNJ) filed an 8-K report on October 16, 2007, to announce its financial results for the third quarter ended September 30, 2007. The filing primarily serves as a notification of the release of their quarterly earnings, attaching the relevant press release and supplementary financial data. Investors should review the attached documents for detailed information on the company's sales, earnings, and overall financial condition during the period. While this 8-K itself does not contain the specific financial figures, it signals the availability of JNJ's performance metrics for the third quarter of 2007. Key insights into the company's operational success, profitability, and any significant financial developments are expected to be found within the incorporated press release and supplementary sales and earnings statements. Investors seeking to understand JNJ's performance during this period should refer to these attached exhibits.
Key Highlights
- 1Johnson & Johnson filed a Form 8-K on October 16, 2007.
- 2The report announces the company's sales and earnings for the third quarter ended September 30, 2007.
- 3The filing includes an attached press release dated October 16, 2007, detailing the Q3 results.
- 4Unaudited comparative supplementary sales data and condensed consolidated statements of earnings for Q3 are also included as exhibits.
- 5The primary purpose of the filing is to provide public access to the company's latest quarterly financial performance.
- 6The report is signed by Stephen J. Cosgrove, Controller and Principal Accounting Officer.